Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults
Abstract Long-term magnesium supplementation improves arterial stiffness, a cardiovascular disease risk marker. Effects on endothelial function may be another mechanism whereby increased magnesium intakes affect cardiovascular risk. Therefore, a 24-week, randomized, double-blind, placebo-controlled...
Main Authors: | Peter J. Joris, Jogchum Plat, Stephan J. L. Bakker, Ronald P. Mensink |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-00205-9 |
Similar Items
-
Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.
by: Sanne M van der Made, et al.
Published: (2015-01-01) -
Improvement of pulse wave velocity and metabolic cardiovascular risk parameters through egg protein hydrolysate intake: A randomized trial in overweight or obese subjects with impaired glucose tolerance or type 2 diabetes
by: Jogchum Plat, et al.
Published: (2019-01-01) -
Effects of Berry Anthocyanins on Cognitive Performance, Vascular Function and Cardiometabolic Risk Markers: A Systematic Review of Randomized Placebo-Controlled Intervention Studies in Humans
by: Sanne Ahles, et al.
Published: (2021-06-01) -
Effects of an 8-week aerobic exercise program on plasma markers for cholesterol absorption and synthesis in older overweight and obese men
by: S. Mashnafi, et al.
Published: (2021-09-01) -
Effects of magnesium citrate, magnesium oxide and magnesium sulfate supplementation on arterial stiffness in healthy overweight individuals: a study protocol for a randomized controlled trial
by: Joëlle C. Schutten, et al.
Published: (2019-05-01)